مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

308
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

147
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EVALUATION OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE ENZYME EXPRESSION EFFECT ON SURVIVAL OF PATIENTS WITH GRADE 4 BRAIN ASTROCYTOMA

Pages

  426-432

Abstract

 Background: High-grade ASTROCYTOMA (Grade 4) or GLIOBLASTOMA MULTIFORME (GBM) are deadly brain tumors. New therapies attempt to increase lifetime and quality of life in patients with malignant ASTROCYTOMA. O6-METHYLGUANINE-DNA METHYLTRANSFERASE (MGMT) enzyme expression may be effective in prognosis and response to treatment of these patients. The aim of this study was assessment of MGMT enzyme expression in patients with ASTROCYTOMA Grade 4.Materials and Methods: In this study, 48 patients with GBM that were treated with surgery, chemotherapy and radiotherapy were investigated and followed-up for 47 months for the survival rate. Pathology blocks of patients were examined for MGMT enzyme expression using immunohistochemistry method.Results: The patients were 34 males and 14 females. The ages ranged from 24 to 77 years, with a mean age of 53.52±13.39 years. There was no significant difference between two groups (positive and negative MGMT enzyme expression) in overall survival (median [range] 11.5 [4-30] vs. 13 [5-22], P=0.9). The results of our study showed that patients although who were undergone near total surgery had higher overall survival than the group of patients who had biopsy only however, it was not significant. Patients who were treated with TEMOZOLOMIDE (TMZ) (Temodal, Merck Canada) had significant overall median survival (14.5) more than the patients who were treated with Procarbazine (Roche, Swiss)-Lomustine (Lilly, USA)-Vincristine (Lilly, USA) regimen (8.75) (P<0.05).Conclusion: O6-METHYLGUANINE-DNA METHYLTRANSFERASE enzyme expression had no effect on survival of patients with Grade 4 brain ASTROCYTOMA TMZ may increase survival rate.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    HEMATI, SIMIN, SAYADI, ALI, MAHZOONI, PARVIN, & SIROUS, MEHRY. (2014). EVALUATION OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE ENZYME EXPRESSION EFFECT ON SURVIVAL OF PATIENTS WITH GRADE 4 BRAIN ASTROCYTOMA. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 19(5), 426-432. SID. https://sid.ir/paper/630390/en

    Vancouver: Copy

    HEMATI SIMIN, SAYADI ALI, MAHZOONI PARVIN, SIROUS MEHRY. EVALUATION OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE ENZYME EXPRESSION EFFECT ON SURVIVAL OF PATIENTS WITH GRADE 4 BRAIN ASTROCYTOMA. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2014;19(5):426-432. Available from: https://sid.ir/paper/630390/en

    IEEE: Copy

    SIMIN HEMATI, ALI SAYADI, PARVIN MAHZOONI, and MEHRY SIROUS, “EVALUATION OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE ENZYME EXPRESSION EFFECT ON SURVIVAL OF PATIENTS WITH GRADE 4 BRAIN ASTROCYTOMA,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 19, no. 5, pp. 426–432, 2014, [Online]. Available: https://sid.ir/paper/630390/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button